Continuum Biosciences
Blacksburg, US · Founded 2017 · Delaware corporation · 1 known investors
Founders & leadership
DS
David SinclairNamed on SEC filing
KH
Kyle HoehnNamed on SEC filing
AT
Alexander Tristan EdwardsNamed on SEC filing
JA
John AmatrudaNamed on SEC filing
WS
Webster SantosNamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$500K disclosed across 1 round · 2017
▶$500KraisedAug 2017 · 1 investors · OtherRule 506(b)
▶$500KraisedAug 2017 · 1 investors · Other
Rule 506(b)Officers, directors & promoters on the filing
- David SinclairDirector
- Kyle HoehnExecutive Officer, Director
- Alexander Tristan EdwardsDirector
- John AmatrudaDirector
- Webster SantosExecutive Officer, Director
- Offering amount
- $10M
- Amount sold
- $500K
- Minimum investment
- $1
- First sale
- Aug 2017
- Incorporated
- Corporation, Delaware, 2017
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- Who are Continuum Biosciences's investors?
- Continuum Biosciences's investors include Life Biosciences.
- How much funding has Continuum Biosciences raised?
- Continuum Biosciences has disclosed $500K raised across 1 round.
- Where is Continuum Biosciences headquartered?
- Continuum Biosciences is headquartered in Blacksburg, US.